Skip to content
1st July 2021

The Anti-kit Antibody, CDX-0159, Reduces Disease Activity and Tryptase Levels in Patients with Chronic Inducible Urticaria

1st June 2020

CDX-0159, an anti-KIT monoclonal antibody, demonstrates dose-dependent reductions in plasma Tryptase and a favorable safety profile in a Phase 1a healthy volunteer study

1st November 2019

CDX-0159, an anti-KIT monoclonal antibody, as a modulator of mast cell-related diseases

Top